Финансовая отчетность за 2023 год. Новые типы совладельцев
А также проверка заблокированных счетов и обеспечительных мер в карточке персоны
Details
LLC analysis company "Arensi Pharma"
Moscow
OGRN: 1137746388350
TIN: 7716744525
Active
Profile views
496
+3 last week
Subscribers
2
+0 last week
Company-related news
31
-9 last week
OKVED2 63.11.1 Total: 6
Activities for databases, information resources creation and usage
Monitoring Notes Reports Contact information

Registers

+7 (▒▒▒) ▒▒▒-▒▒-▒▒
0 0

Open sources

+7 (▒▒▒) ▒▒▒-▒▒-▒▒
0 0
+7 (▒▒▒) ▒▒▒-▒▒-▒▒
0 0
+7 (▒▒▒) ▒▒▒-▒▒-▒▒
0 0
+7 (▒▒▒) ▒▒▒-▒▒-▒▒
0 0

Domains

rncph.ru — official site

Open sources

▒▒▒▒▒▒▒▒▒▒▒▒▒
152,88
mln ₽, 2023
Revenue
+₽27mln
CEO
Gubardin Maksim Sergeevich
100
Reliability Score
CEO
Gubardin Maksim Sergeevich
11
years
Established
April 29, 2013
City Moscow
152,88
mln ₽, 2023
Revenue
+₽27mln
10
Connections
+0 last week
54
Employees
+16 last year
Report an issue

Please describe the issue and specify your E-mail so we could contact you.

Your message has not been sent. Please try again.

Send

By submitting your personal information, you consent to its processing in accordance with Privacy Policy.